VITASPRING BIOMEDICAL CO. LTD.
Public company- Headquarters
- RIVERSIDE, California
- Ticker
- VSBC
- CIK
- 0001697884
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOSsu-Chuan Lai | Sep 10, 2026 | Departed |
| Chairman of the BoardShao-Hsiang Shih | Sep 10, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- NRC HEALTH
CFO appointed: Trent Green
- OneMedNet Corp
Class III director appointed: Kenneth Alleyne
- iSpecimen Inc.
CEO departs: Katharyn Field
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Plant closure: Hanover, MD
- Executive departure
CEO departs: Ssu-Chuan Lai
Ssu-Chuan Lai, Chief Executive Officer of VITASPRING BIOMEDICAL CO. LTD., resigns the role, effective September 7, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 10, 2026Role: Chief Executive Officer
- Executive appointment
CEO appointed: Jing-Zhou Chen
Jing-Zhou Chen was named Chief Executive Officer of VITASPRING BIOMEDICAL CO. LTD., effective September 7, 2026. Jing-Zhou Chen succeeds Ssu-Chuan Lai. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 10, 2026Role: Chief Executive Officer
- Executive appointment
Chairman of the Board appointed: Shao-Hsiang Shih
Shao-Hsiang Shih was named Chairman of the Board of VITASPRING BIOMEDICAL CO. LTD., effective September 7, 2026. Shao-Hsiang Shih succeeds Ssu-Chuan Lai. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 10, 2026Role: Chairman of the Board
Last verified Nov 9, 2026